The BTK Inhibitors Market has seen significant growth in recent years, driven by their increasing application in treating blood cancers and autoimmune disorders. Bruton’s tyrosine kinase (BTK) is a pivotal enzyme in B-cell receptor signaling, making it a prime target for therapeutic interventions. By inhibiting BTK, these drugs offer innovative treatment options for conditions such as...